Stockreport

Iovance Q1 Earnings Review: Not Enough Data To Draw Conclusions On Amtagvi [Seeking Alpha]

Iovance Biotherapeutics, Inc.  (IOVA) 
Last iovance biotherapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: iovance.com
PDF Iovance secured a historic approval for a first solid tumor targeting cell therapy in mid-Feb, triggering overnight gains of close to 100%. Now, the market is turning [Read more]